AI assistant
ARTELO BIOSCIENCES, INC. — Director's Dealing 2021
Feb 17, 2021
35163_dirs_2021-02-17_72ae7c6a-d883-4978-86ff-796a92a74d31.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARTELO BIOSCIENCES, INC. (ARTL)
CIK: 0001621221
Period of Report: 2021-02-12-05:00
Reporting Person: Blayney Douglas (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-12-05:00 | Stock Option (right to buy) | $2.66 | A | 139500 | Acquired | 2031-02-12-05:00 | Common Stock (139500) | Direct |
Footnotes
F1: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and fifty percent (50%) of the shares subject to the option shall vest on the two (2) year anniversary of the Vesting Commencement Date, such that the option shall be fully vested on the two (2) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean February 12, 2021.